Tactile Systems Technology (TCMD) Net Income towards Common Stockholders (2015 - 2026)
Tactile Systems Technology's (TCMD) quarterly Net Income towards Common Stockholders came in at -$1.8 million in Q1 2026, up 40.66% year-on-year from -$1.3 million in Q1 2025, and down 116.71% on a QoQ basis from $10.5 million in Q4 2025.
Tactile Systems Technology (TCMD) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has 12 years of Net Income towards Common Stockholders data on file, last reported at -$1.8 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 40.66% year-over-year to -$1.8 million in Q1 2026; TTM through Mar 2026 was $20.2 million, a 24.6% increase from a year earlier, with the FY2025 full-year figure at $19.0 million, up 12.26% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$1.8 million, down from $10.5 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for TCMD reached as high as $22.3 million in Q3 2023 and fell as low as -$15.6 million in Q1 2022.
- Historically, Net Income towards Common Stockholders has averaged $2.6 million across 5 years, with a median of $3.2 million in 2025.
- Across the five-year window, Net Income towards Common Stockholders slumped 587.03% in 2022 and soared 4398.0% in 2024, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $4.6 million in 2022, then soared by 77.49% to $8.2 million in 2023, then gained by 19.02% to $9.8 million in 2024, then advanced by 8.06% to $10.5 million in 2025, then plunged by 116.71% to -$1.8 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$1.8 million in Q1 2026, $10.5 million in Q4 2025, and $8.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Tactile Systems Technology | 624.49 Mn | 534.30 Mn | 57.61 Mn | -1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.76 Mn |
| Dec 31, 2025 | 10.55 Mn |
| Sep 30, 2025 | 8.24 Mn |
| Jun 30, 2025 | 3.22 Mn |
| Mar 31, 2025 | -2.97 Mn |
| Dec 31, 2024 | 9.76 Mn |
| Sep 30, 2024 | 5.16 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Sep 30, 2023 | 22.29 Mn |
| Jun 30, 2023 | -100,000.00 |
| Mar 31, 2023 | -1.89 Mn |
| Dec 31, 2022 | 4.62 Mn |
| Sep 30, 2022 | -2.28 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -15.57 Mn |
| Dec 31, 2021 | -7.50 Mn |
| Sep 30, 2021 | -3.36 Mn |
| Jun 30, 2021 | 1.31 Mn |